Bill filed by Neal would devastate life sciences
Legislation would vastly expand price controls on drugs
By 
THE BIOTECHNOLOGY and pharmaceutical sector in the Boston area is about to hit some rough water. According to the Brussels-based consulting firm Vital Transformation, the prescription drug price controls in the Inflation Reduction Act (IRA) will result in job losses of at least 500,000 nationwide over the next decade, about 30,000 of which will come(...)